THE RESTRUCTURING OF JAPANESE RESEARCH AND DEVELOPMENT: THE INCREASING IMPACT OF SCIENCE ON JAPANESE R&D

Concerns about the competitiveness of Japan's high-technology industries has prompted a number of recent reforms seeking to strengthen the ability of Japanese firms to utilize scientific discoveries, often originating in universities, in their R&D activities. Using an original panel data set comprised of over 300 leading Japanese R&D-performing firms, we seek to measure changes in the connection between science and Japanese industrial technology by using data on the citations to scientific articles appearing in the U.S. patents of these firms. Econometric analysis suggests that this connection is substantial, that it has grown over time, and that it contributes significantly to the research productivity of Japanese firms. Our data suggest that scientific research originating outside Japan, particularly in the United States, generates a particularly important component of these knowledge spillovers, and that measured knowledge flows are systematically related to firms' efforts to forge research alliances with American firms and universities. We integrate our econometric findings with data on the scientific publications of Japanese firms as well as a series of semi-structured interviews with Japanese R&D managers, academic scientists, and other experts. These various sources reveal that the interaction between Japanese firms and universities, domestic and foreign, is complex and takes a number of forms, only some of which are well captured by our data. The implications of this for public policy and for future research on this topic are discussed at length.

Disentangling The Effects Of The Employee Benefits On Employee Productivity

This study aimed to investigate the effects of employee benefits on employee productivity. There are conflicting views, positive and negative, with regard to the effect of employee benefits on employee productivity. Overall, we found that employee benefits have a positive impact on employee productivity through the embodied effect (direct effect). Specifically, according to a workplace panel survey in Korea conducted between 2005 and 2009, an increase of one unit in employee benefits leads to an increase of employee productivity by about 7.9%. In addition, we found that such effect is stronger in the manufacturing industry than in the non-manufacturing industry. Although there is no difference in the effect of benefits between large firms and small and medium-sized firms, the labor-embodied effect is stronger in large firms, and the capital-embodied effect is salient in small and medium-sized firms

Image-Object-Specific Prompt Learning for Few-Shot Class-Incremental Learning

While many FSCIL studies have been undertaken, achieving satisfactory performance, especially during incremental sessions, has remained challenging. One prominent challenge is that the encoder, trained with an ample base session training set, often underperforms in incremental sessions. In this study, we introduce a novel training framework for FSCIL, capitalizing on the generalizability of the Contrastive Language-Image Pre-training (CLIP) model to unseen classes. We achieve this by formulating image-object-specific (IOS) classifiers for the input images. Here, an IOS classifier refers to one that targets specific attributes (like wings or wheels) of class objects rather than the image's background. To create these IOS classifiers, we encode a bias prompt into the classifiers using our specially designed module, which harnesses key-prompt pairs to pinpoint the IOS features of classes in each session. From an FSCIL standpoint, our framework is structured to retain previous knowledge and swiftly adapt to new sessions without forgetting or overfitting. This considers the updatability of modules in each session and some tricks empirically found for fast convergence. Our approach consistently demonstrates superior performance compared to state-of-the-art methods across the miniImageNet, CIFAR100, and CUB200 datasets. Further, we provide additional experiments to validate our learned model's ability to achieve IOS classifiers. We also conduct ablation studies to analyze the impact of each module within the architecture.Comment: 8 pages, 4 figures, 4 table

A Herbal Medicine, Gongjindan

This study protocol aims to explore the effectiveness, safety, and cost-effectiveness of a herbal medication, Gongjindan (GJD), in patients with chronic dizziness. This will be a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group, clinical trial. Seventy-eight patients diagnosed with Meniere’s disease, psychogenic dizziness, or dizziness of unknown cause will be randomized and allocated to either a GJD or a placebo group in a 1 : 1 ratio. Participants will be orally given 3.75 g GJD or placebo in pill form once a day for 56 days. The primary outcome measure will be the Dizziness Handicap Inventory score. Secondary outcome measures will be as follows: severity (mean vertigo scale and visual analogue scale) and frequency of dizziness, balance function (Berg Balance Scale), fatigue (Fatigue Severity Scale) and deficiency pattern/syndrome (qi blood yin yang-deficiency questionnaire) levels, and depression (Korean version of Beck’s Depression Inventory) and anxiety (State-Trait Anxiety Inventory) levels. To assess safety, adverse events, including laboratory test results, will be monitored. Further, the incremental cost-effectiveness ratio will be calculated based on quality-adjusted life years (from the EuroQoL five dimensions’ questionnaire) and medical expenses. Data will be statistically analyzed at a significance level of 0.05 (two-sided). This trial is registered with ClinicalTrials.gov NCT03219515, in July 2017

Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004

<p>Abstract</p> <p>Background</p> <p>Using non-steroidal anti-inflammatory drugs (NSAIDs) as a case, we used Taiwan's National Health Insurance (NHI) database, to empirically explore the association between policy interventions (price regulation, new drug entry, and an information shock) and drug expenditures, utilization, and market structure between 2001 and 2004.</p> <p>Methods</p> <p>All NSAIDs prescribed in ambulatory visits in the NHI system during our study period were included and aggregated quarterly. Segmented regression analysis for interrupted time series was used to examine the associations between two price regulations, two new drug entries (cyclooxygennase-2 inhibitors) and the rofecoxib safety signal and expenditures and utilization of all NSAIDs. Herfindahl index (HHI) was applied to further examine the association between these interventions and market structure of NSAIDs.</p> <p>Results</p> <p>New entry was the only variable that was significantly correlated with changes of expenditures (positive change, p = 0.02) and market structure of the NSAIDs market in the NHI system. The correlation between price regulation (first price regulation, p = 0.62; second price regulation, p = 0.26) and information shock (p = 0.31) and drug expenditure were not statistically significant. There was no significant change in the prescribing volume of NSAIDs per rheumatoid arthritis (RA) or osteoarthritis (OA) ambulatory visit during the observational period. The market share of NSAIDs had also been largely substituted by these new drugs up to 50%, in a three-year period and resulted in a more concentrated market structure (HHI 0.17).</p> <p>Conclusions</p> <p>Our empirical study found that new drug entry was the main driving force behind escalating drug spending, especially by altering the market share.</p

Inflammatory cytokines and biofilm production sustain Staphylococcus aureus outgrowth and persistence: A pivotal interplay in the pathogenesis of Atopic Dermatitis

Individuals with Atopic dermatitis (AD) are highly susceptible to Staphylococcus aureus colonization. However, the mechanisms driving this process as well as the impact of S. aureus in AD pathogenesis are still incompletely understood. In this study, we analysed the role of biofilm in sustaining S. aureus chronic persistence and its impact on AD severity. Further we explored whether key inflammatory cytokines overexpressed in AD might provide a selective advantage to S. aureus. Results show that the strength of biofilm production by S. aureus correlated with the severity of the skin lesion, being significantly higher (P < 0.01) in patients with a more severe form of the disease as compared to those individuals with mild AD. Additionally, interleukin (IL)-β and interferon γ (IFN-γ), but not interleukin (IL)-6, induced a concentration-dependent increase of S. aureus growth. This effect was not observed with coagulase-negative staphylococci isolated from the skin of AD patients. These findings indicate that inflammatory cytokines such as IL1-β and IFN-γ, can selectively promote S. aureus outgrowth, thus subverting the composition of the healthy skin microbiome. Moreover, biofilm production by S. aureus plays a relevant role in further supporting chronic colonization and disease severity, while providing an increased tolerance to antimicrobials

Evolutionary Instability of Symbiotic Function in Bradyrhizobium japonicum

Bacterial mutualists are often acquired from the environment by eukaryotic hosts. However, both theory and empirical work suggest that this bacterial lifestyle is evolutionarily unstable. Bacterial evolution outside of the host is predicted to favor traits that promote an independent lifestyle in the environment at a cost to symbiotic function. Consistent with these predictions, environmentally-acquired bacterial mutualists often lose symbiotic function over evolutionary time. Here, we investigate the evolutionary erosion of symbiotic traits in Bradyrhizobium japonicum, a nodulating root symbiont of legumes. Building on a previous published phylogeny we infer loss events of nodulation capability in a natural population of Bradyrhizobium, potentially driven by mutation or deletion of symbiosis loci. Subsequently, we experimentally evolved representative strains from the symbiont population under host-free in vitro conditions to examine potential drivers of these loss events. Among Bradyrhizobium genotypes that evolved significant increases in fitness in vitro, two exhibited reduced symbiotic quality, but no experimentally evolved strain lost nodulation capability or evolved any fixed changes at six sequenced loci. Our results are consistent with trade-offs between symbiotic quality and fitness in a host free environment. However, the drivers of loss-of-nodulation events in natural Bradyrhizobium populations remain unknown